Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study

BACKGROUND: Glioblastoma (GBM) is the most common malignant brain tumor in adults. The prognosis of GBM patients is poor. Even with active standard treatment, the median overall survival is only 14.6 months. It is therefore critical to ascertain recurrence and search for factors that influence the p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Transl Med
Asıl Yazarlar: Zheng, Lin, Zhou, Zhi-Rui, Shi, Minghan, Chen, Haiyan, Yu, Qian-Qian, Yang, Yang, Liu, Lihong, Zhang, Lili, Guo, Yinglu, Zhou, Xiaofeng, Li, Chao, Wei, Qichun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105825/
https://ncbi.nlm.nih.gov/pubmed/33987269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-673
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller